Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Andrew Sparks, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
University of Arkansas, Fayetteville, ARBS2003Physics
University of Arkansas for Medical Sciences, Little Rock, ARMD2007Medicine
Washington University, St. Louis, MO2010Internal Medicine
Harvard Medical School, Boston, MAMMSc2014Patient-oriented research
Brigham and Women's Hospital, Boston, MA2014Rheumatology
2012
BWH Fellow Teaching Award
2013
ACR Distinguished Fellow Award
2014
RRF Scientist Development Award
2014 - 2021
NIH Loan Repayment Award
2016
BWH DOM Chair's Research Award
2017
BWH DOM Early Career Mentoring Award
2019
HMS Program Award for Culture of Excellence in Mentoring
2021
EULAR Clinical Abstract Award
2021
BWH DOM Chair's Research Award

Overview
Our group has an overall focus on using patient-oriented and epidemiologic research studies to evaluate the etiology, outcomes, and public health burden of rheumatic diseases such as rheumatoid arthritis (RA). In particular, we perform studies to evaluate the genetic, environmental, serologic, and familial risk factors for RA, clinical trials for RA prevention, RA outcomes research focusing on the respiratory burden of RA, evaluate the effect of metabolic factors such as weight loss on RA outcomes, and investigate rheumatic manifestations of osseous sarcoidosis. We use large population-based studies for these studies, including the Nurses’ Health Studies, the Studies for the Etiology of RA, the Partners electronic medical record, the Brigham RA Sequential Study, and pharmacy claims databases. We also perform clinical trials including the Personalized Risk Estimator for RA (PRE-RA) Family Study, the Strategy to Prevent the Onset of Clinically-Apparent RA (StopRA), and the Cardiovascular Inflammation Reduction Trial (CIRT).

Mentoring
Available: 04/05/22, Expires: 06/01/23

We are currently focusing on the interplay between lung inflammation and rheumatoid arthritis susceptibility and outcomes. We hypothesize that immune tolerance loss and RA-related autoantibody production occur at mucosal surfaces of the lung contributing to both RA risk and outcomes. We are testing these hypotheses using a variety of study designs, such as the Nurses' Health Studies, a large institutional RA registry, EMR data, pharmacy claims data, the Partners Biobank, and clinical trials.


Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AR077607 (SPARKS, JEFFREY ANDREW) Sep 27, 2021 - Jun 30, 2026
    NIH
    Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
    Role: Principal Investigator
  2. P30AR070253 (NIGROVIC, PETER; KARLSON, ELIZABETH; SPARKS, JEFFREY ANDREW) Aug 1, 2021 - Jul 31, 2026
    NIH
    Joint Biology Consortium Resource-based Center
    Role: Multi-Principal Investigator
  3. R Bridge Award (SPARKS, JEFFREY ANDREW) Aug 10, 2020 - Aug 9, 2022
    Rheumatology Research Foundation
    Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease
    Role: Principal Investigator
  4. R03AR075886 (SPARKS, JEFFREY ANDREW) Jul 3, 2019 - Jun 30, 2021
    NIH
    Respiratory Diseases, Genetics, and Rheumatoid Arthritis Risk
    Role: Principal Investigator
  5. K Supplement Award (SPARKS, JEFFREY ANDREW) Sep 5, 2018 - Sep 4, 2020
    Rheumatology Research Foundation
    Rheumatoid Arthritis-Related Autoantibodies and Respiratory Function/Structure
    Role: Principal Investigator

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Patel NJ, Cook C, Vanni K, Fu X, Wang X, Kawano Y, Qian G, Hang B, Srivatsan S, Banasiak EP, Kowalski E, Bade K, Zhang Y, Sparks JA, Wallace ZS. Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases. Ann Rheum Dis. 2022 Nov 28. PMID: 36442978.
    Citations:    
  2. Cook C, Patel NJ, Fu X, Wang X, Kawano Y, Vanni KMM, Qian G, Banasiak E, Kowalski E, Choi HK, Zhang Y, Sparks JA, Wallace ZS. Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines against COVID-19 infection among patients with systemic autoimmune rheumatic diseases on immunomodulatory medications. J Rheumatol. 2022.
  3. Coler-Reilly A, Graef ER, Kim AHJ, Liew JW, Putman MS, Sattui SE, Young KJ, Sparks JA. Social media for research discourse, dissemination, and collaboration in rheumatology. Rheumatol Immunol Res. 2022.
  4. Reid P, Sparks JA, Bass AR. Steroid dose and duration, immortal time bias, and survival after immune-related adverse events. JAMA Oncol. 2022.
  5. Cui J, Malspeis S, Choi MY, Lu B, Sparks JA, Yoshida K, Costenbader KH. Risk prediction models for incident systemic lupus erythematosus among women using genetics, family history, and lifestyle and environmental factors. Semin Arthritis Rheum. 2022.
  6. McDermott GC, Sparks JA. Air pollutants, genetics, and the mucosal paradigm for rheumatoid arthritis risk. Environ Health Perspect. 2022.
  7. Kronzer VL, Sparks JA. Occupational inhalants, genetics, and the respiratory mucosal paradigm for ACPA-positive rheumatoid arthritis. Ann Rheum Dis. 2022.
  8. Patel NJ, Wang X, Fu X, Kawano Y, Cook C, Vanni KMM, Qian G, Banasiak E, Kowalski E, Zhang Y, Sparks JA, Wallace ZS. Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study. Semin Arthritis Rheum. 2022 Oct 26; 58:152108. PMID: 36347211; PMCID: PMC9605731.
    Citations:    Fields:    
  9. Ugarte-Gil MF, Alarcón GS, Seet AM, Izadi Z, Montgomery AD, Duarte-García A, Gilbert EL, Valenzuela-Almada MO, Wise L, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Wallace Z, Jacobsohn L, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus (SLE) Patients from the United States: Data from the COVID-19 Global Rheumatology Alliance. Arthritis Care Res (Hoboken). 2022 Oct 14. PMID: 36239292.
    Citations:    Fields:    
  10. Sasaki T, Bracero S, Keegan J, Chen L, Cao Y, Stevens E, Qu Y, Wang G, Nguyen J, Sparks JA, Holers VM, Alves SE, Lederer JA, Costenbader KH, Rao DA. Longitudinal Immune Cell Profiling in Patients With Early Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 Nov; 74(11):1808-1821. PMID: 35644031.
    Citations: 1     Fields:    
  11. Juge PA, Granger B, Debray MP, Ebstein E, Louis-Sidney F, Kedra J, Doyle TJ, Borie R, Constantin A, Combe B, Flipo RM, Mariette X, Vittecoq O, Saraux A, Carvajal-Alegria G, Sibilia J, Berenbaum F, Kannengiesser C, Boileau C, Sparks JA, Crestani B, Fautrel B, Dieudé P. A Risk Score to Detect Subclinical Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol. 2022 Nov; 74(11):1755-1765. PMID: 35583934.
    Citations:    Fields:    
  12. Li H, Wallace ZS, Sparks JA, Lu N, Wei J, Xie D, Wang Y, Zeng C, Lei G, Zhang Y. Risk of COVID-19 Among Unvaccinated and Vaccinated Patients With Rheumatoid Arthritis: A General Population Study. Arthritis Care Res (Hoboken). 2022 Sep 26. PMID: 36161711; PMCID: PMC9538842.
    Citations: 1     Fields:    
  13. Kronzer VL, Lennon RJ, Sparks JA, Myasoedova E, Davis JM, Crowson CS. Association between work physical activity, dietary factors, and risk of rheumatoid arthritis. Semin Arthritis Rheum. 2022 Dec; 57:152100. PMID: 36166875.
    Citations:    Fields:    
  14. Maguire S, Al-Emadi S, Alba P, Aguiar MC, Lawati TA, Alle G, Bermas B, Bhana S, Branimir A, Bulina I, Clowse M, Cogo K, Colunga I, Cook C, Cortez KJ, Dao K, Gianfrancesco M, Gore-Massey M, Gossec L, Grainger R, Hausman J, Hsu TYT, Hyrich K, Isnardi C, Kawano Y, Kilding R, Kusevich DA, Lawson-Tovey S, Liew J, McCarthy E, Montgumery A, Moyano S, Nasir N, Padjen I, Papagoras C, Patel NJ, Pera M, Pisoni C, Pons-Estel G, Quiambao AL, Quintana R, Ruderman E, Sattui S, Savio V, Sciascia S, Sencarova M, Morales RS, Siddique F, Sirotich E, Sparks J, Strangfeld A, Sufka P, Tanner H, Tissera Y, Wallace Z, Werner ML, Wise L, Worthing AB, Zell J, Zepa J, Machado PM, Yazdany J, Robinson P, Conway R. Obstetric Outcomes in Women with Rheumatic Disease and COVID-19 in the Context of Vaccination Status. Rheumatology (Oxford). 2022 Sep 19. PMID: 36124987.
    Citations:    Fields:    
  15. Figueroa-Parra G, Gilbert EL, Valenzuela-Almada MO, Vallejo S, Neville MR, Patel NJ, Cook C, Fu X, Hagi R, McDermott GC, Dilorio MA, Masto L, Vanni KMM, Kowalski E, Qian G, Zhang Y, Wallace ZS, Duarte-García A, Sparks JA. Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study. Lancet Rheumatol. 2022 Nov; 4(11):e765-e774. PMID: 36118532; PMCID: PMC9472567.
    Citations: 2     
  16. Choi MY, Malspeis S, Sparks JA, Cui J, Yoshida K, Costenbader KH. Association of Sleep Deprivation and the Risk of Developing Systemic Lupus Erythematosus among Women. Arthritis Care Res (Hoboken). 2022 Sep 12. PMID: 36094865.
    Citations:    Fields:    
  17. Xie D, Choi HK, Dalbeth N, Wallace ZS, Sparks JA, Lu N, Zeng C, Li X, Wei J, Lei G, Zhang Y. Gout and Excess Risk of Severe SARS-CoV-2 Infection Among Vaccinated Individuals: A General Population Study. Arthritis Rheumatol. 2022 Sep 09. PMID: 36082457; PMCID: PMC9537980.
    Citations:    Fields:    
  18. Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop K, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr., Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel T, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer PC, Legge A, Lo M, Lockwood M, Sadun RE, Showalter K, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res. 2022.
  19. Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop K, Arasaratnam RJ, Baden LR, Berard R, Bridges SL Jr., Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel T, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer PC, Legge A, Lo M, Lockwood M, Sadun RE, Showalter K, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J. 2022 American College of Rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2022.
  20. DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larché MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpízar-Rodríguez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-García A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2022 09; 8(2). PMID: 36104117; PMCID: PMC9475962.
    Citations: 1     Translation:Humans
  21. Jatuworapruk K, Montgomery A, Gianfrancesco M, Conway R, Durcan L, Graef ER, Jayatilleke A, Keen H, Kilian A, Young K, Carmona L, Cogo AK, Duarte-García A, Gossec L, Hasseli R, Hyrich KL, Langlois V, Lawson-Tovey S, Malcata A, Mateus EF, Schafer M, Scirè CA, Sigurdardottir V, Sparks JA, Strangfeld A, Xavier RM, Bhana S, Gore-Massy M, Hausmann J, Liew JW, Sirotich E, Sufka P, Wallace Z, Machado PM, Yazdany J, Grainger R, Robinson PC. Characteristics and Outcomes of People With Gout Hospitalized Due to COVID-19: Data From the COVID-19 Global Rheumatology Alliance Physician-Reported Registry. ACR Open Rheumatol. 2022 Nov; 4(11):948-953. PMID: 36000538; PMCID: PMC9539246.
    Citations:    
  22. Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TY, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave. Ann Rheum Dis. 2022 Dec; 81(12):1742-1749. PMID: 35944947.
    Citations: 1     Fields:    Translation:Humans
  23. Esposito AJ, Sparks JA, Gill RR, Hatabu H, Schmidlin EJ, Hota PV, Poli S, Fletcher EA, Xiong W, Frits ML, Iannaccone CK, Prado M, Zaccardelli A, Marshall A, Dellaripa PF, Weinblatt ME, Shadick NA, Rosas IO, Doyle TJ. Screening for preclinical parenchymal lung disease in rheumatoid arthritis. Rheumatology (Oxford). 2022 08 03; 61(8):3234-3245. PMID: 34875040; PMCID: PMC9348774.
    Citations:    Fields:    
  24. Izadi Z, Gianfrancesco MA, Schmajuk G, Jacobsohn L, Katz P, Rush S, Ja C, Taylor T, Shidara K, Danila MI, Wysham KD, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ljung L, Scirè CA, Carrara G, Hachulla E, Richez C, Cacoub P, Thomas T, Santos MJ, Bernardes M, Hasseli R, Regierer A, Schulze-Koops H, Müller-Ladner U, Pons-Estel G, Tanten R, Nieto RE, Pisoni CN, Tissera YS, Xavier R, Lopes Marques CD, Pileggi GCS, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Gore-Massy M, Wallace ZS, Yazdany J. Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study. Lancet Rheumatol. 2022 Sep; 4(9):e603-e613. PMID: 35909441; PMCID: PMC9313519.
    Citations: 2     
  25. Izadi Z, Gianfrancesco MA, Aguirre A, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Seet AM, Schmajuk G, Jacobsohn L, Katz P, Rush S, Al-Emadi S, Sparks JA, Hsu TY, Patel NJ, Wise L, Gilbert E, Duarte-García A, Valenzuela-Almada MO, Ugarte-Gil MF, Ribeiro SLE, de Oliveira Marinho A, de Azevedo Valadares LD, Giuseppe DD, Hasseli R, Richter JG, Pfeil A, Schmeiser T, Isnardi CA, Reyes Torres AA, Alle G, Saurit V, Zanetti A, Carrara G, Labreuche J, Barnetche T, Herasse M, Plassart S, Santos MJ, Rodrigues AM, Robinson PC, Machado PM, Sirotich E, Liew JW, Hausmann JS, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Yazdany J. Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry. ACR Open Rheumatol. 2022 Oct; 4(10):872-882. PMID: 35869686; PMCID: PMC9350083.
    Citations:    
  26. Putman M, Berquist JB, Ruderman EM, Sparks JA. Reply to “Desk-rejections: Not without due deliberation”. J Rheumatol. 2022.
  27. Li H, Dalbeth N, Wallace ZS, Sparks JA, Li X, Zeng C, Wang Y, Xie D, Lei G, Wei J, Zhang Y. Risk of gout flares after COVID-19 vaccination: A case-crossover study. Semin Arthritis Rheum. 2022 10; 56:152059. PMID: 35797765; PMCID: PMC9239705.
    Citations:    Fields:    
  28. Rider LG, Parks CG, Wilkerson J, Schiffenbauer AI, Kwok RK, Noroozi Farhadi P, Nazir S, Ritter R, Sirotich E, Kennedy K, Larche MJ, Levine M, Sattui SE, Liew JW, Harrison CO, Moni TT, Miller AK, Putman M, Hausmann J, Simard JF, Sparks JA, Miller FW. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology (Oxford). 2022 06 28; 61(SI2):SI143-SI150. PMID: 35460240; PMCID: PMC9248066.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  29. Sparks JA, Tedeschi SK. Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment. Lancet Respir Med. 2022 09; 10(9):813-815. PMID: 35772415; PMCID: PMC9236564.
    Citations:    Fields:    
  30. Mehta P, Redhead G, Nair A, Sparks JA, Porter JC. Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis? Clin Rheumatol. 2022 10; 41(10):2925-2928. PMID: 35729371.
    Citations:    Fields:    Translation:Humans
  31. Barbhaiya M, Hart JE, Malspeis S, Tedeschi SK, VoPham T, Sparks JA, Karlson EW, Laden F, Costenbader KH. Association of Ultraviolet-B Radiation and Risk of SLE among Women in the Nurses' Health Studies. Arthritis Care Res (Hoboken). 2022 Jun 20. PMID: 35724272.
    Citations:    Fields:    
  32. Kawano Y, Patel NJ, Wang X, Cook CE, Vanni KMM, Kowalski EN, Banasiak EP, Qian G, DiIorio M, Hsu TYT, Weinblatt ME, Todd DJ, Wallace ZS, Sparks JA. Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron. medRxiv. 2022 Jun 20. PMID: 35765565; PMCID: PMC9238187.
    Citations: 1     
  33. McDermott G, Sparks JA. Quantitative chest imaging and prediction of mortality in rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford). 2022 Jun 02. PMID: 35652728.
    Citations:    Fields:    
  34. Putman M, Berquist JB, Ruderman EM, Sparks JA. Any Given Monday: Association Between Desk Rejections and Weekend Manuscript Submissions to Rheumatology Journals. J Rheumatol. 2022 06; 49(6):652-653. PMID: 35649541.
    Citations:    Fields:    Translation:Humans
  35. Joerns EK, Adams TN, Sparks JA, Newton CA, Bermas B, Karp D, Makris UE. Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know. Curr Rheumatol Rep. 2022 06; 24(6):213-226. PMID: 35650373; PMCID: PMC9159646.
    Citations:    Fields:    Translation:Humans
  36. Kowalski EN, Qian G, Vanni KMM, Sparks JA. A Roadmap for Investigating Preclinical Autoimmunity Using Patient-Oriented and Epidemiologic Study Designs: Example of Rheumatoid Arthritis. Front Immunol. 2022; 13:890996. PMID: 35693829; PMCID: PMC9175569.
    Citations:    Fields:    Translation:Humans
  37. Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study. Semin Arthritis Rheum. 2022 08; 55:152025. PMID: 35617780; PMCID: PMC9116968.
    Citations: 2     Fields:    Translation:Humans
  38. Paik JJ, Sparks JA, Kim AHJ. Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases. Curr Opin Pharmacol. 2022 08; 65:102243. PMID: 35636384; PMCID: PMC9058024.
    Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
  39. Kim AHJ, Sparks JA. Immunosuppression and SARS-CoV-2 breakthrough infections. Lancet Rheumatol. 2022 Jun; 4(6):e379-e380. PMID: 35527809; PMCID: PMC9054102.
    Citations: 1     
  40. Prisco L, Moll M, Doyle TJ, Cho MH, Sparks JA. Reply. Arthritis Rheumatol. 2022 06; 74(6):1096-1097. PMID: 35133086.
    Citations:    Fields:    
  41. Sparks JA, Singh N, Wallace ZS. Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases. Lancet Rheumatol. 2022 Jun; 4(6):e380-e382. PMID: 35441152; PMCID: PMC9009834.
    Citations:    
  42. Marchand NE, Sparks JA, Malspeis S, Yoshida K, Prisco L, Zhang X, Costenbader K, Hu F, Karlson EW, Lu B. Long-term weight changes and risk of rheumatoid arthritis among women in a prospective cohort: a marginal structural model approach. Rheumatology (Oxford). 2022 04 11; 61(4):1430-1439. PMID: 34247242; PMCID: PMC8996781.
    Citations:    Fields:    Translation:Humans
  43. Liew J, Gianfrancesco M, Harrison C, Izadi Z, Rush S, Lawson-Tovey S, Jacobsohn L, Ja C, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Schäfer M, Frãzao-Mateus E, Bulina I, Stafford F, Tufan A, Graver C, Yardimci GK, Zepa J, Al Emadi S, Cook C, Abutiban F, Dey D, Katigbak G, Kaufman L, Kowalski E, Martínez-Martínez MU, Patel NJ, Reyes-Cordero G, Salido E, Smith E, Snow D, Sparks J, Wise L, Bhana S, Gore-Massy M, Grainger R, Hausmann J, Sirotich E, Sufka P, Wallace Z, Machado PM, Robinson PC, Yazdany J. SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry. RMD Open. 2022 04; 8(1). PMID: 35387864; PMCID: PMC8987210.
    Citations: 3     Translation:HumansCells
  44. Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-García A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AHJ, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte-Gil MF, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis. Arthritis Rheumatol. 2022 05; 74(5):766-775. PMID: 34807517; PMCID: PMC9011807.
    Citations: 12     Fields:    Translation:HumansCells
  45. Patel NJ, D'Silva KM, Li MD, Hsu TYT, DiIorio M, Fu X, Cook C, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Zhang Y, Kalpathy-Cramer J, Sparks JA, Wallace ZS. Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores. Arthritis Care Res (Hoboken). 2022 Mar 21. PMID: 35313091; PMCID: PMC9081965.
    Citations:    Fields:    
  46. McDermott G, Gill R, Gagne S, Byrne S, Huang W, Wang X, Prisco LC, Zaccardelli A, Martin LW, Masto L, Kronzer VL, Shadick N, Dellaripa PF, Doyle TJ, Sparks JA. Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)-associated Bronchiectasis: Role of RA-related Autoantibodies. J Rheumatol. 2022 07; 49(7):672-679. PMID: 35293341; PMCID: PMC9250607.
    Citations:    Fields:    Translation:Humans
  47. McDermott G, Gill R, Gagne S, Byrne S, Huang W, Cui J, Prisco L, Zaccardelli A, Martin L, Kronzer VL, Moll M, Cho MH, Shadick N, Dellaripa PF, Doyle T, Sparks JA. Associations of the MUC5B Promoter Variant with Timing of Interstitial Lung Disease and Rheumatoid Arthritis Onset. Rheumatology (Oxford). 2022 Mar 15. PMID: 35289841.
    Citations:    Fields:    
  48. Young K, Yeoh SA, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks J, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A. The impact of COVID-19 on rheumatology training-results from the COVID-19 Global Rheumatology Alliance trainee survey. Rheumatol Adv Pract. 2022; 6(1):rkac001. PMID: 35392427; PMCID: PMC8982766.
    Citations:    
  49. Ugarte-Gil MF, Alarcón GS, Izadi Z, Duarte-García A, Reátegui-Sokolova C, Clarke AE, Wise L, Pons-Estel GJ, Santos MJ, Bernatsky S, Ribeiro SLE, Al Emadi S, Sparks JA, Hsu TY, Patel NJ, Gilbert EL, Valenzuela-Almada MO, Jönsen A, Landolfi G, Fredi M, Goulenok T, Devaux M, Mariette X, Queyrel V, Romão VC, Sequeira G, Hasseli R, Hoyer B, Voll RE, Specker C, Baez R, Castro-Coello V, Maldonado Ficco H, Reis Neto ET, Ferreira GAA, Monticielo OAA, Sirotich E, Liew J, Hausmann J, Sufka P, Grainger R, Bhana S, Costello W, Wallace ZS, Jacobsohn L, Taylor T, Ja C, Strangfeld A, Mateus EF, Hyrich KL, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schäfer M, Machado PM, Robinson PC, Gianfrancesco M, Yazdany J. Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance. Ann Rheum Dis. 2022 07; 81(7):970-978. PMID: 35172961; PMCID: PMC8882632.
    Citations: 2     Fields:    Translation:Humans
  50. Simmons DP, Nguyen HN, Gomez-Rivas E, Jeong Y, Jonsson AH, Chen AF, Lange JK, Dyer GS, Blazar P, Earp BE, Coblyn JS, Massarotti EM, Sparks JA, Todd DJ, Rao DA, Kim EY, Brenner MB. SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci Immunol. 2022 02 11; 7(68):eabf2846. PMID: 35148199; PMCID: PMC8991457.
    Citations: 1     Fields:    Translation:HumansCells
  51. Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D'Silva KM, Fu X, Wang J, Prisco LC, Kowalski E, Zaccardelli A, Martin LW, Qian G, Hsu TY, Wallace ZS, Sparks JA. DMARD disruption, disease flare, and prolonged symptom duration after acute COVID-19 among participants with rheumatic disease: A prospective study. medRxiv. 2022 Feb 09. PMID: 35169813; PMCID: PMC8845434.
    Citations:    
  52. Putman M, Kennedy K, Sirotich E, Liew JW, Sattui SE, Moni TT, Akpabio AA, Alpizar-Rodriguez D, Angevare S, Beesley RP, Berenbaum F, Bulina I, Chock YPE, Conway R, Duarte-García A, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard R, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AHJ, Liew DFL, Lo C, Mateus EF, Miller B, Mingolla S, Nudel M, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Zamora-Tehozol EA, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché MJ, Levine M, Foster G, Thabane L, Hausmann JS, Sparks JA, Simard JF. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Lancet Rheumatol. 2022 Apr; 4(4):e237-e240. PMID: 35156060; PMCID: PMC8824526.
    Citations: 3     
  53. Choi MY, Hahn J, Malspeis S, Stevens EF, Karlson EW, Sparks JA, Yoshida K, Kubzansky L, Costenbader KH. Reply. Arthritis Rheumatol. 2022 03; 74(3):543-544. PMID: 35118833.
    Citations:    Fields:    
  54. Vanni KM, Patel NJ, DiIorio M, Kowalski E, Qian G, Cook CE, Ritter SY, Wallace ZS, Sparks JA. Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy. RMD Open. 2022 02; 8(1). PMID: 35110366; PMCID: PMC8811273.
    Citations: 1     Translation:HumansCells
  55. Cunningham-Bussel A, Wang J, Prisco LC, Martin LW, Vanni KMM, Zaccardelli A, Nasrallah M, Gedmintas L, MacFarlane LA, Shadick NA, Awad MM, Rahma O, LeBoeuf NR, Gravallese EM, Sparks JA. Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer. Arthritis Rheumatol. 2022 03; 74(3):527-540. PMID: 34397169; PMCID: PMC8847547.
    Citations: 3     Fields:    Translation:Humans
  56. Hahn J, Malspeis S, Choi MY, Stevens E, Karlson EW, Lu B, Cui J, Yoshida K, Kubzansky L, Sparks JA, Costenbader KH. Association of Healthy Lifestyle Behaviors and the Risk of Developing Rheumatoid Arthritis Among Women. Arthritis Care Res (Hoboken). 2022 Jan 18. PMID: 35040282; PMCID: PMC9289074.
    Citations:    Fields:    
  57. Choi MY, Hahn J, Malspeis S, Stevens EF, Karlson EW, Sparks JA, Yoshida K, Kubzansky L, Costenbader KH. Association of a Combination of Healthy Lifestyle Behaviors With Reduced Risk of Incident Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022 02; 74(2):274-283. PMID: 34313398; PMCID: PMC8792100.
    Citations: 6     Fields:    Translation:Humans
  58. Kronzer VL, Huang W, Crowson CS, DavisIII JM, Vassallo R, Doyle TJ, Losina E, Sparks JA. Timing of sinusitis and other respiratory tract diseases and risk of rheumatoid arthritis. Semin Arthritis Rheum. 2022 02; 52:151937. PMID: 35042150; PMCID: PMC8820230.
    Citations: 1     Fields:    Translation:Humans
  59. Wallace ZS, Sparks JA. Therapeutic Drug Monitoring for Immune-Mediated Inflammatory Diseases. JAMA. 2021 12 21; 326(23):2370-2372. PMID: 34932096.
    Citations:    Fields:    
  60. Patel NJ, D'Silva KM, Hsu TY, DiIorio M, Fu X, Cook C, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Zhang Y, Sparks JA, Wallace ZS. Coronavirus Disease 2019 Outcomes Among Recipients of Anti-CD20 Monoclonal Antibodies for Immune-Mediated Diseases: A Comparative Cohort Study. ACR Open Rheumatol. 2022 Mar; 4(3):238-246. PMID: 34890478; PMCID: PMC8916578.
    Citations: 1     
  61. Yeoh SA, Young K, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks J, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A. Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees. ACR Open Rheumatol. 2022 Feb; 4(2):128-133. PMID: 34791821; PMCID: PMC8652624.
    Citations:    
  62. Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, de Sousa Studart SA, Araujo NC, Knight A, Rozza D, Quartuccio L, Samson M, Bally S, Maria AT, Chazerain P, Hasseli R, Müller-Ladner U, Hoyer BF, Voll R, Torres RP, Luis M, Ribeirio SLE, Al-Emadi S, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Wise L, Gilbert E, Almada MV, Duarte-García A, Ugarte-Gil M, Jacobsohn L, Izadi Z, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Sirotich E, Hausmann JS, Sufka P, Bhana S, Liew JW, Grainger R, Machado PM, Wallace ZS, Yazdany J, Robinson PC. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. Lancet Rheumatol. 2021 Dec; 3(12):e855-e864. PMID: 34778843; PMCID: PMC8570701.
    Citations: 7     
  63. Yoshida K, Wang J, Malspeis S, Marchand N, Lu B, Prisco LC, Martin LW, Ford JA, Costenbader KH, Karlson EW, Sparks JA. Passive Smoking Throughout the Life Course and the Risk of Incident Rheumatoid Arthritis in Adulthood Among Women. Arthritis Rheumatol. 2021 12; 73(12):2219-2228. PMID: 34406709; PMCID: PMC8976916.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  64. Kronzer VL, Huang W, Zaccardelli A, Crowson CS, Davis JM, Vassallo R, Doyle TJ, Losina E, Sparks JA. Association of Sinusitis and Upper Respiratory Tract Diseases With Incident Rheumatoid Arthritis: A Case-control Study. J Rheumatol. 2022 04; 49(4):358-364. PMID: 34654732; PMCID: PMC8977280.
    Citations: 4     Fields:    Translation:Humans
  65. Izadi Z, Brenner EJ, Mahil SK, Dand N, Yiu ZZN, Yates M, Ungaro RC, Zhang X, Agrawal M, Colombel JF, Gianfrancesco MA, Hyrich KL, Strangfeld A, Carmona L, Mateus EF, Lawson-Tovey S, Klingberg E, Cuomo G, Caprioli M, Cruz-Machado AR, Mazeda Pereira AC, Hasseli R, Pfeil A, Lorenz HM, Hoyer BF, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Seet AM, Al Emadi S, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Isnardi CA, Quintana R, Soriano ER, Hsu TY, D'Silva KM, Sparks JA, Patel NJ, Xavier RM, Marques CDL, Kakehasi AM, Flipo RM, Claudepierre P, Cantagrel A, Goupille P, Wallace ZS, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Griffiths CEM, Barker JN, Smith CH, Yazdany J, Kappelman MD. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Netw Open. 2021 10 01; 4(10):e2129639. PMID: 34661663; PMCID: PMC8524310.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  66. Prisco L, Moll M, Wang J, Hobbs BD, Huang W, Martin LW, Kronzer VL, Huang S, Silverman EK, Doyle TJ, Cho MH, Sparks JA. Relationship Between Rheumatoid Arthritis and Pulmonary Function Measures on Spirometry in the UK Biobank. Arthritis Rheumatol. 2021 11; 73(11):1994-2002. PMID: 33982900; PMCID: PMC8568623.
    Citations: 1     Fields:    Translation:Humans
  67. Hahn J, Leatherwood C, Malspeis S, Liu X, Lu B, Roberts AL, Sparks JA, Karlson EW, Feldman CH, Munroe ME, James JA, Kubzansky LD, Costenbader KH. Associations Between Smoking and Systemic Lupus Erythematosus-Related Cytokines and Chemokines Among US Female Nurses. Arthritis Care Res (Hoboken). 2021 11; 73(11):1583-1589. PMID: 32619290; PMCID: PMC8522201.
    Citations: 7     Fields:    Translation:Humans
  68. Sparks JA, Vanni KMM, Sparks MA, Xu C, Santacroce LM, Glynn RJ, Ridker PM, Solomon DH. Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical Trial. J Am Soc Nephrol. 2021 Sep 22. PMID: 34551998.
    Citations:    Fields:    
  69. Cook C, Patel NJ, D'Silva KM, Hsu TY, DiIorio M, Prisco L, Martin LW, Vanni K, Zaccardelli A, Todd D, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases. Ann Rheum Dis. 2022 02; 81(2):289-291. PMID: 34489304; PMCID: PMC8791428.
    Citations: 14     Fields:    Translation:HumansCells
  70. Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021 09; 7(3). PMID: 34493645; PMCID: PMC8424419.
    Citations: 30     Translation:HumansCellsPHPublic Health
  71. Bermas BL, Gianfrancesco M, Tanner HL, Seet AM, Aguiar MC, Al Adhoubi NK, Al Emadi S, Cunha BM, Flood R, Kusevich DA, McCarthy EM, Patel NJ, Ruderman EM, Sattui SE, Sciascia S, Siddique F, Valenzuela-Almada MO, Wise LM, Worthing AB, Zell J, Bhana S, Costello W, Duarte-Garcia A, Grainger R, Gossec L, Hausmann JS, Hyrich K, Lawson-Tovey S, Liew JW, Sirotich E, Sparks JA, Sufka P, Wallace ZS, Machado PM, Strangfeld A, Clowse MEB, Yazdany J, Robinson PC. COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. J Rheumatol. 2022 01; 49(1):110-114. PMID: 34470798.
    Citations: 2     Fields:    Translation:HumansCells
  72. Sparks JA, Wallace ZS, Robinson PC. Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021 09 01; 33(5):412-418. PMID: 34171857.
    Citations: 3     Fields:    Translation:HumansCells
  73. Liu Y, Xia B, Li B, Sparks JA, He Q, Yuan J, Zhou B. No association between recent antibiotic use and risk of rheumatoid arthritis: results from two prospective cohort studies. Expert Opin Drug Saf. 2022 Jan; 21(1):121-126. PMID: 34403275.
    Citations: 1     Fields:    Translation:Humans
  74. Wallace ZS, Sparks JA, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 23. PMID: 34426400.
    Citations:    Fields:    
  75. Roofeh D, Barratt SL, Wells AU, Kawano-Dourado L, Tashkin D, Strand V, Seibold J, Proudman S, Brown KK, Dellaripa PF, Doyle T, Leonard T, Matteson EL, Oddis CV, Solomon JJ, Sparks JA, Vassallo R, Maxwell L, Beaton D, Christensen R, Townsend W, Khanna D. Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process. Semin Arthritis Rheum. 2021 12; 51(6):1331-1341. PMID: 34493396; PMCID: PMC8678187.
    Citations: 1     Fields:    Translation:Humans
  76. Martin LW, Prisco LC, Huang W, McDermott G, Shadick NA, Doyle TJ, Sparks JA. Prevalence and risk factors of bronchiectasis in rheumatoid arthritis: A systematic review and meta-analysis. Semin Arthritis Rheum. 2021 10; 51(5):1067-1080. PMID: 34450505; PMCID: PMC8453125.
    Citations: 1     Fields:    Translation:Humans
  77. Sparks JA, Wallace ZS, Seet AM, Robinson PC, Machado PM, Yazdany J. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis. 2021 Aug 13. PMID: 34389604.
    Citations:    Fields:    
  78. Barbhaiya M, Tedeschi S, Sparks JA, Leatherwood C, Karlson EW, Willett WC, Lu B, Costenbader KH. Association of Dietary Quality With Risk of Incident Systemic Lupus Erythematosus in the Nurses' Health Study and Nurses' Health Study II. Arthritis Care Res (Hoboken). 2021 09; 73(9):1250-1258. PMID: 32936999; PMCID: PMC7960564.
    Citations: 5     Fields:    Translation:HumansAnimalsPHPublic Health
  79. Putman M, Sattui SE, Sparks JA, Liew JW, Grainger R, Duarte-García A. Reply. Arthritis Rheumatol. 2021 09; 73(9):1767-1768. PMID: 33779057; PMCID: PMC8251029.
    Citations:    Fields:    
  80. Sparks JA. Towards clinical significance of the MUC5B promoter variant and risk of rheumatoid arthritis-associated interstitial lung disease. Ann Rheum Dis. 2021 12; 80(12):1503-1504. PMID: 34344705.
    Citations:    Fields:    Translation:HumansCells
  81. Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ, Kim SC. Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients. Rheumatology (Oxford). 2021 08 02; 60(8):3689-3698. PMID: 33462611; PMCID: PMC8328504.
    Citations: 4     Fields:    Translation:Humans
  82. Hausmann JS, Kennedy K, Simard JF, Liew JW, Sparks JA, Moni TT, Harrison C, Larché MJ, Levine M, Sattui SE, Semalulu T, Foster G, Surangiwala S, Thabane L, Beesley RP, Durrant KL, Mateus EF, Mingolla S, Nudel M, Palmerlee CA, Richards DP, Liew DFL, Hill CL, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Sirotich E. Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases. Lancet Rheumatol. 2021 Oct; 3(10):e707-e714. PMID: 34316727; PMCID: PMC8298011.
    Citations: 14     
  83. Bouzit L, Malspeis S, Sparks JA, Cui J, Karlson EW, Yoshida K, Costenbader KH. Assessing improved risk prediction of rheumatoid arthritis by environmental, genetic, and metabolomic factors. Semin Arthritis Rheum. 2021 10; 51(5):1016-1022. PMID: 34416623; PMCID: PMC8475497.
    Citations: 1     Fields:    Translation:Humans
  84. Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millán I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 07; 73(7):1108-1123. PMID: 34101376.
    Citations: 42     Fields:    Translation:Humans
  85. Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millán I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 07; 73(7):924-939. PMID: 34101387; PMCID: PMC9273041.
    Citations: 27     Fields:    Translation:Humans
  86. Sparks JA. Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door. J Rheumatol. 2021 Nov; 48(11):1629-1631. PMID: 34074680.
    Citations:    Fields:    Translation:Humans
  87. Hsu TY, D'Silva KM, Patel NJ, Wang J, Mueller AA, Fu X, Prisco L, Martin L, Vanni KMM, Zaccardelli A, Cook C, Choi HK, Zhang Y, Gravallese EM, Wallace ZS, Sparks JA. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study. Lancet Rheumatol. 2021 Sep; 3(9):e638-e647. PMID: 34095857; PMCID: PMC8163294.
    Citations: 10     
  88. Zaccardelli A, Sparks JA. Challenges and Opportunities of Targeted Behavioral Interventions for Groups at Risk for Developing Rheumatoid Arthritis. Healthcare (Basel). 2021 May 28; 9(6). PMID: 34071429.
    Citations: 1     
  89. Sparks JA, Wallace ZS, Seet AM, Gianfrancesco MA, Izadi Z, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Lawson-Tovey S, Trupin L, Rush S, Katz P, Schmajuk G, Jacobsohn L, Wise L, Gilbert EL, Duarte-García A, Valenzuela-Almada MO, Pons-Estel GJ, Isnardi CA, Berbotto GA, Hsu TY, D'Silva KM, Patel NJ, Kearsley-Fleet L, Schäfer M, Ribeiro SLE, Al Emadi S, Tidblad L, Scirè CA, Raffeiner B, Thomas T, Flipo RM, Avouac J, Seror R, Bernardes M, Cunha MM, Hasseli R, Schulze-Koops H, Müller-Ladner U, Specker C, Souza VA, Mota LMHD, Gomides APM, Dieudé P, Nikiphorou E, Kronzer VL, Singh N, Ugarte-Gil MF, Wallace B, Akpabio A, Thomas R, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Robinson PC, Machado PM, Yazdany J. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry. Ann Rheum Dis. 2021 09; 80(9):1137-1146. PMID: 34049860.
    Citations: 47     Fields:    Translation:HumansCells
  90. McDermott GC, Doyle TJ, Sparks JA. Interstitial lung disease throughout the rheumatoid arthritis disease course. Curr Opin Rheumatol. 2021 05 01; 33(3):284-291. PMID: 33625044; PMCID: PMC8268047.
    Citations: 6     Fields:    Translation:Humans
  91. Hsu TY, D'Silva KM, Patel NJ, Fu X, Wallace ZS, Sparks JA. Incident systemic rheumatic disease following COVID-19. Lancet Rheumatol. 2021 Jun; 3(6):e402-e404. PMID: 33842894.
    Citations: 6     
  92. Zaccardelli A, Liu X, Ford JA, Cui J, Lu B, Chu SH, Schur PH, Speyer CB, Costenbader KH, Robinson WH, Sokolove J, Karlson EW, Camargo CA, Sparks JA. Elevated Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma. Arthritis Care Res (Hoboken). 2021 04; 73(4):498-509. PMID: 31961487; PMCID: PMC7371499.
    Citations: 8     Fields:    Translation:HumansCells
  93. Costenbader KH, DiIorio M, Chu SH, Cui J, Sparks JA, Lu B, Moss L, Kelmenson L, Feser M, Edison J, Clish C, Lasky-Su J, Deane KD, Karlson EW. Circulating blood metabolite trajectories and risk of rheumatoid arthritis among military personnel in the Department of Defense Biorepository. Ann Rheum Dis. 2021 08; 80(8):989-996. PMID: 33753325; PMCID: PMC8455711.
    Citations: 2     Fields:    Translation:Humans
  94. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by Shanoj et al. Ann Rheum Dis. 2021 Mar 10. PMID: 33692020.
    Citations: 4     Fields:    
  95. Gianfrancesco MA, Leykina LA, Izadi Z, Taylor T, Sparks JA, Harrison C, Trupin L, Rush S, Schmajuk G, Katz P, Jacobsohn L, Hsu TY, D'Silva KM, Serling-Boyd N, Wallwork R, Todd DJ, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Machado PM, Robinson PC, Yazdany J. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Arthritis Rheumatol. 2021 03; 73(3):374-380. PMID: 33146001; PMCID: PMC8467766.
    Citations: 23     Fields:    Translation:HumansCells
  96. Yoshida K, Lin TC, Wei MY, Malspeis S, Chu SH, Camargo CA, Raby BA, Choi HK, Tedeschi SK, Barbhaiya M, Lu B, Costenbader KH, Karlson EW, Sparks JA. Roles of Postdiagnosis Accumulation of Morbidities and Lifestyle Changes in Excess Total and Cause-Specific Mortality Risk in Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 02; 73(2):188-198. PMID: 31811708; PMCID: PMC7275877.
    Citations: 12     Fields:    Translation:Humans
  97. Kronzer VL, Crowson CS, Sparks JA, Myasoedova E, Davis J. Family History of Rheumatic, Autoimmune, and Nonautoimmune Diseases and Risk of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 02; 73(2):180-187. PMID: 31785183; PMCID: PMC7260093.
    Citations: 1     Fields:    Translation:Humans
  98. Strangfeld A, Schäfer M, Gianfrancesco MA, Lawson-Tovey S, Liew JW, Ljung L, Mateus EF, Richez C, Santos MJ, Schmajuk G, Scirè CA, Sirotich E, Sparks JA, Sufka P, Thomas T, Trupin L, Wallace ZS, Al-Adely S, Bachiller-Corral J, Bhana S, Cacoub P, Carmona L, Costello R, Costello W, Gossec L, Grainger R, Hachulla E, Hasseli R, Hausmann JS, Hyrich KL, Izadi Z, Jacobsohn L, Katz P, Kearsley-Fleet L, Robinson PC, Yazdany J, Machado PM. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2021 07; 80(7):930-942. PMID: 33504483.
    Citations: 152     Fields:    Translation:HumansCells
  99. D'Silva KM, Serling-Boyd N, Hsu TY, Sparks JA, Wallace ZS. SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease. Ann Rheum Dis. 2021 06; 80(6):817-819. PMID: 33436385; PMCID: PMC8482283.
    Citations: 14     Fields:    Translation:HumansCells
  100. Egeli BH, Sparks JA, Kim AHJ, Liew JW. Hydroxychloroquine for the treatment of COVID-19 and its potential cardiovascular toxicity: Hero or villain? Best Pract Res Clin Rheumatol. 2021 03; 35(1):101658. PMID: 33483287; PMCID: PMC7775793.
    Citations:    Fields:    Translation:HumansCells
  101. Nambiar AM, Walker CM, Sparks JA. Monitoring and management of fibrosing interstitial lung diseases: a narrative review for practicing clinicians. Ther Adv Respir Dis. 2021 Jan-Dec; 15:17534666211039771. PMID: 34477452; PMCID: PMC8422822.
    Citations: 3     Fields:    Translation:Humans
  102. Sparks JA, Malspeis S, Hahn J, Wang J, Roberts AL, Kubzansky LD, Costenbader KH. Depression and Subsequent Risk for Incident Rheumatoid Arthritis Among Women. Arthritis Care Res (Hoboken). 2021 01; 73(1):78-89. PMID: 32937012.
    Citations: 6     Fields:    Translation:Humans
  103. Sattui SE, Graef ER, Liew JW, Sparks JA, Kim AHJ. Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'. Expert Rev Clin Immunol. 2021 01; 17(1):105-107. PMID: 33290667.
    Citations:    Fields:    Translation:Humans
  104. Sparks JA. Clinical application of personalized rheumatoid arthritis risk information: Translational epidemiology leading to precision medicine. Expert Rev Precis Med Drug Dev. 2021; 6(3):147-149. PMID: 34124370.
    Citations:    
  105. Serling-Boyd N, D'Silva KM, Hsu TY, Wallwork R, Fu X, Gravallese EM, Jorge AM, Zhang Y, Choi H, Sparks JA, Wallace ZS. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. 2021 05; 80(5):660-666. PMID: 33257496.
    Citations: 33     Fields:    Translation:HumansCells
  106. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 01; 73(1):36-47. PMID: 32741139; PMCID: PMC7435536.
    Citations: 28     Fields:    Translation:HumansCells
  107. Kronzer VL, Huang W, Dellaripa PF, Huang S, Feathers V, Lu B, Iannaccone CK, Gill RR, Hatabu H, Nishino M, Crowson CS, Davis JM, Weinblatt ME, Shadick NA, Doyle TJ, Sparks JA. Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease. J Rheumatol. 2021 05; 48(5):656-663. PMID: 33191286; PMCID: PMC8096643.
    Citations: 7     Fields:    Translation:Humans
  108. Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293. PMID: 33176080; PMCID: PMC7673303.
    Citations: 363     Fields:    Translation:HumansCells
  109. Chu SH, Cui J, Sparks JA, Lu B, Tedeschi SK, Speyer CB, Moss L, Feser ML, Kelmenson LB, Mewshaw EA, Edison JD, Deane KD, Clish C, Lasky-Su J, Karlson EW, Costenbader KH. Circulating plasma metabolites and risk of rheumatoid arthritis in the Nurses' Health Study. Rheumatology (Oxford). 2020 11 01; 59(11):3369-3379. PMID: 32310291; PMCID: PMC7590418.
    Citations: 10     Fields:    Translation:Humans
  110. Xiang L, Low AHL, Leung YY, Fong W, Gandhi M, Xin X, Uy EJ, Sparks JA, Karlson EW, Thumboo J. Improving sensitivity of the connective tissue disease screening questionnaire: A comparative study of various scoring methods. Lupus. 2021 Jan; 30(1):35-44. PMID: 33092467.
    Citations:    Fields:    Translation:Humans
  111. Sparks JA, Dellaripa PF, Glynn RJ, Paynter NP, Xu C, Ridker PM, Solomon DH. Pulmonary Adverse Events in Patients Receiving Low-Dose Methotrexate in the Randomized, Double-Blind, Placebo-Controlled Cardiovascular Inflammation Reduction Trial. Arthritis Rheumatol. 2020 12; 72(12):2065-2071. PMID: 32741143; PMCID: PMC7722048.
    Citations: 5     Fields:    Translation:Humans
  112. Singh N, Baer RJ, Swaminathan M, Saurabh S, Sparks JA, Bandoli G, Flowers E, Jelliffe-Pawlowski LL, Ryckman KK. Pregnancy after bariatric surgery in women with rheumatic diseases and association with adverse birth outcomes. Surg Obes Relat Dis. 2021 Feb; 17(2):406-413. PMID: 33097446.
    Citations:    Fields:    Translation:Humans
  113. Huang S, Doyle TJ, Hammer MM, Byrne SC, Huang W, Marshall AA, Iannaccone CK, Huang J, Feathers V, Weinblatt ME, Dellaripa PF, Shadick NA, Sparks JA. Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: Prevalence, risk factors, and impact on mortality. Semin Arthritis Rheum. 2020 12; 50(6):1216-1225. PMID: 33059295.
    Citations: 5     Fields:    Translation:Humans
  114. Cui J, Raychaudhuri S, Karlson EW, Speyer C, Malspeis S, Guan H, Sparks JA, Ni H, Liu X, Stevens E, Williams JN, Davenport EE, Knevel R, Costenbader KH. Interactions Between Genome-Wide Genetic Factors and Smoking Influencing Risk of Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020 11; 72(11):1863-1871. PMID: 32969204; PMCID: PMC7722161.
    Citations: 3     Fields:    Translation:Humans
  115. Huang S, Kronzer VL, Dellaripa PF, Deane KD, Bolster MB, Nagaraja V, Khanna D, Doyle TJ, Sparks JA. Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment. Curr Treatm Opt Rheumatol. 2020 Dec; 6(4):337-353. PMID: 33282632; PMCID: PMC7709915.
    Citations: 10     
  116. Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 07; 16(7):659-666. PMID: 32620062.
    Citations: 25     Fields:    Translation:HumansCellsPHPublic Health
  117. Duarte-García A, Graef ER, Liew JW, Konig MF, Kim AH, Sparks JA. Response to: 'Correspondence on 'Festina lente: hydroxychloroquine, COVID-19and the role of the rheumatologist' by Graef et al' by Lo et al. Ann Rheum Dis. 2020 Aug 07. PMID: 32769149; PMCID: PMC8075104.
    Citations:    Fields:    
  118. Ugarte-Gil MF, Konig MF, Korsten P, Berenbaum F, Kim AH, Sparks JA. Response to: 'Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis' by Singer et al. Ann Rheum Dis. 2020 Aug 05. PMID: 32759257; PMCID: PMC8075121.
    Citations:    Fields:    
  119. Scheetz MH, Konig MF, Robinson PC, Sparks JA, Kim AHJ. A Pharmacokinetics-Informed Approach to Navigating Hydroxychloroquine Shortages in Patients With Rheumatic Disease During the COVID-19 Pandemic. ACR Open Rheumatol. 2020 Aug; 2(8):491-495. PMID: 32725866.
    Citations: 4     
  120. Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum. 2020 10; 50(5):1191-1201. PMID: 32931985.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  121. Solomon DH, Sparks JA. Adverse Effects of Low-Dose Methotrexate. Ann Intern Med. 2020 07 21; 173(2):167. PMID: 32687751.
    Citations:    Fields:    Translation:Humans
  122. Marchand NE, Sparks JA, Tedeschi SK, Malspeis S, Costenbader KH, Karlson EW, Lu B. Abdominal Obesity in Comparison with General Obesity and Risk of Developing Rheumatoid Arthritis in Women. J Rheumatol. 2021 02; 48(2):165-173. PMID: 32669445.
    Citations: 7     Fields:    Translation:Humans
  123. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu TY, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al. Ann Rheum Dis. 2022 08; 81(8):e135. PMID: 32660976.
    Citations:    Fields:    Translation:Humans
  124. Liew JW, Graef ER, Sparks JA, Kim AH. Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al. Ann Rheum Dis. 2022 08; 81(8):e155. PMID: 32647030.
    Citations:    Fields:    Translation:Humans
  125. Yuan J, Zhang C, Sparks JA, Malspeis S, Tsoi KK, Kim JH, Fisher BA, Gao F, Sumerlin T, Liu Y, Liu Y, Pan Y, He Y, Sung JJY. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study. Aliment Pharmacol Ther. 2020 08; 52(3):449-458. PMID: 32598046.
    Citations: 5     Fields:    Translation:Humans
  126. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'Incidence of severe COVID-19 in a Spanish cohort of 1037 patients with rheumatic diseases treated with biologics and JAK-inhibitors' by Jovani et al. Ann Rheum Dis. 2022 07; 81(7):e132. PMID: 32586919.
    Citations:    Fields:    Translation:Humans
  127. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Sparks JA, Wallace ZS. Response to: 'COVID-19 in patients with rheumatological diseases treated with Anti-TNF' by Brito et al and 'Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences' by Zhao et al. Ann Rheum Dis. 2021 05; 80(5):e64. PMID: 32546600.
    Citations:    Fields:    Translation:HumansCells
  128. Hahn J, Leatherwood C, Malspeis S, Liu X, Lu B, Roberts AL, Sparks JA, Karlson EW, Feldman CH, Munroe ME, James JA, Kubzansky LD, Costenbader KH. Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE. Lupus. 2020 Jul; 29(8):976-982. PMID: 32507075.
    Citations: 3     Fields:    Translation:Humans
  129. Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866. PMID: 32471903; PMCID: PMC7299648.
    Citations: 385     Fields:    Translation:HumansCellsPHPublic Health
  130. Graef ER, Liew JW, Kim AH, Sparks JA. Response to: 'Case series of acute arthritis in COVID-19 admission' by López-González et al. Ann Rheum Dis. 2021 04; 80(4):e59. PMID: 32471896.
    Citations:    Fields:    Translation:Humans
  131. D'Silva KM, Serling-Boyd N, Wallwork R, Hsu T, Fu X, Gravallese EM, Choi HK, Sparks JA, Wallace ZS. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'. Ann Rheum Dis. 2020 09; 79(9):1156-1162. PMID: 32457048; PMCID: PMC7456555.
    Citations: 90     Fields:    Translation:HumansCellsPHPublic Health
  132. Cho SK, Doyle TJ, Lee H, Jin Y, Tong AY, Ortiz AJS, Sparks JA, Kim SC. Validation of claims-based algorithms to identify interstitial lung disease in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2020 08; 50(4):592-597. PMID: 32480097.
    Citations: 5     Fields:    Translation:Humans
  133. Graef ER, Liew JW, Kim AH, Sparks JA. Response to: 'Antimalarial use and arrhythmias in COVID-19 and rheumatic patients: a matter of dose and inflammation?' by Erre et al. Ann Rheum Dis. 2021 03; 80(3):e30. PMID: 32424027.
    Citations: 2     Fields:    Translation:Humans
  134. Prisco LC, Martin LW, Sparks JA. Inhalants other than personal cigarette smoking and risk for developing rheumatoid arthritis. Curr Opin Rheumatol. 2020 05; 32(3):279-288. PMID: 32141952; PMCID: PMC7233294.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  135. Ingraham NE, Boulware D, Sparks MA, Schacker T, Benson B, Sparks JA, Murray T, Connett J, Chipman JG, Charles A, Tignanelli CJ. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2. Crit Care. 2020 04 28; 24(1):182. PMID: 32345336; PMCID: PMC7187670.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  136. Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA. Festina lente: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 06; 79(6):734-736. PMID: 32295786; PMCID: PMC7359879.
    Citations: 13     Fields:    Translation:HumansCellsPHPublic Health
  137. Centor RM, Kim AH, Sparks JA. Web Exclusive. Annals On Call - COVID-19: Is Chloroquine the Answer? Ann Intern Med. 2020 05 05; 172(9):OC1. PMID: 32271869.
    Citations: 2     Fields:    
  138. Ford JA, Liu X, Chu SH, Lu B, Cho MH, Silverman EK, Costenbader KH, Camargo CA, Sparks JA. Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study. Arthritis Rheumatol. 2020 05; 72(5):704-713. PMID: 32129572; PMCID: PMC7188599.
    Citations: 15     Fields:    Translation:Humans
  139. Kronzer VL, Wang L, Liu H, Davis JM, Sparks JA, Crowson CS. Investigating the impact of disease and health record duration on the eMERGE algorithm for rheumatoid arthritis. J Am Med Inform Assoc. 2020 04 01; 27(4):601-605. PMID: 32134444.
    Citations: 2     Fields:    Translation:Humans
  140. Huang S, He X, Doyle TJ, Zaccardelli A, Marshall AA, Friedlander HM, Blaustein RB, Smith EA, Cui J, Iannaccone CK, Mahmoud TG, Weinblatt ME, Dellaripa PF, Shadick NA, Sparks JA. Correction to: Association of rheumatoid arthritis-related autoantibodies with pulmonary function test abnormalities in a rheumatoid arthritis registry. Clin Rheumatol. 2020 04; 39(4):1371-1372. PMID: 32020443.
    Citations:    Fields:    
  141. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 06 16; 172(12):819-821. PMID: 32227189; PMCID: PMC7138335.
    Citations: 98     Fields:    Translation:HumansCellsPHPublic Health
  142. Mahler M, Martinez-Prat L, Sparks JA, Deane KD. Precision medicine in the care of rheumatoid arthritis: Focus on prediction and prevention of future clinically-apparent disease. Autoimmun Rev. 2020 May; 19(5):102506. PMID: 32173516.
    Citations: 11     Fields:    Translation:Humans
  143. Solomon DH, Glynn RJ, Karlson EW, Lu F, Corrigan C, Colls J, Xu C, MacFadyen J, Barbhaiya M, Berliner N, Dellaripa PF, Everett BM, Pradhan AD, Hammond SP, Murray M, Rao DA, Ritter SY, Rutherford A, Sparks JA, Stratton J, Suh DH, Tedeschi SK, Vanni KMM, Paynter NP, Ridker PM. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial. Ann Intern Med. 2020 03 17; 172(6):369-380. PMID: 32066146; PMCID: PMC7229518.
    Citations: 29     Fields:    Translation:Humans
  144. Sparks JA. No association of bariatric surgery with reduced rheumatoid arthritis risk: where do we go from here? Rheumatology (Oxford). 2020 02 01; 59(2):275-276. PMID: 31687773.
    Citations:    Fields:    Translation:Humans
  145. Friedlander HM, Ford JA, Zaccardelli A, Terrio AV, Cho MH, Sparks JA. Obstructive lung diseases and risk of rheumatoid arthritis. Expert Rev Clin Immunol. 2020 01; 16(1):37-50. PMID: 31774329; PMCID: PMC6980732.